Monthly Archives: July 2013

Zyoxel

zyoxel

Zyoxel develops and supplies cell culture platforms that support more physiologically relevant tissue models for pharmaceutical drug discovery applications:

  • Enabling the study of cellular behaviour and function in a more in vivo-like environment
  • Providing responses which closely replicate human clinical responses
  • Reducing the use of animals in testing
  • Reducing late stage clinical trial failures by identifying unsafe drugs and through selection of the most efficacious candidates earlier in development
  • Enabling more cost efficient drug development meaning that new medicines can be bought to market more quickly
Liver Chip enables cell culture in a 3D perfused state for advanced toxicity and efficacy testing

Liver Chip enables cell culture in a 3D perfused state for advanced toxicity and efficacy testing

Advertisements

Leave a comment

July 31, 2013 · 9:06 pm

Nexeon

Nexeon-location

Nexeon (www.nexeon.co.uk), is a unique silicon anode technology. Nexeon offers a significant step forward in lithium ion battery performance in a range of applications. the battery materials and licensing company, has signed a strategic partnership agreement with WACKER Chemie AG, and WACKER has taken a strategic stake in Nexeon.

Nexeon is developing silicon materials to replace carbon as the anode of lithium ion (Li-ion) batteries. This will lead to the production of rechargeable batteries with higher charge density, enabling consumers to use devices such as laptops and smart phones for longer before needing to recharge them. Stronger battery performance is also key to the wider adoption of electric and hybrid vehicles.
The partnership with Wacker will involve the two companies working together to scale-up the production of Nexeon’s silicon anode technology to commercial volumes. WACKER has strong research and chemical process capabilities as well as extensive production expertise in speciality materials and will be able to leverage its engineering and manufacturing expertise to accelerate Nexeon’s scale-up plans.

 

Leave a comment

July 30, 2013 · 8:30 pm

Ceres Power

Ceres Power (AIM:CWR, http://www.cerespower.com) is a developer of intermediate temperature solid oxide fuel cell technology. On 12th March the company announced its intention of raising  £9.7 million net through a placing to raise £8.7m and open offer to raise £1m, at 8 pence per share.
The proceeds of the fundraise are intended provide sufficient capital to take Ceres through the next stage of OEM engagements. Following the deployment of these funds, the Ceres core cell and FCM technology platform will be proven to be suitable for product development programmes with several OEMs in multiple geographies.
IP Group will invest £2 million in this round, and will thereafter hold 24.8% of Ceres’ enlarged issued share capital. Other investors in the round include existing shareholders ORA (Guernsey) Limited and Sarasin & Partners LLP, and new investor Henderson Global Investors Limited.

http://www.cwpower.com/

Leave a comment

July 30, 2013 · 8:08 pm

Peraso

perasoPeraso Enables Next Generation Mobiles. Peraso’s 60 GHz ICs unlock 9 GHz of unlicensed spectrum in the 57-66GHz band, and thus acts as an enabling technology for a variety of new applications in the mobile realm.

In the mobile infrastructure market, 60 GHz is viewed as a primary technology choice for small cell backhaul. With features such as high bandwidth, narrow beamwidth and low latency, 60 GHz provides carriers with a viable, cost effective option to traditional backhaul methods such as fiber or microwave.

In mobile devices such as smartphones and tablets, 60 GHz provides a wireless alternative to existing wired standards like USB3.0 or HDMI. Peraso’s WiGig 60 GHz chipsets address this market with industry leading energy efficiency, a compact form factor, and sub-frame glass to glass latency.

Leave a comment

July 28, 2013 · 11:32 pm

FOTA

fota

FOTA : Dr. Tony Carusone at the Univ of Toronto has developed patent-pending breakthrough technology that both efficiently and affordably performs optoelectronic conversion for high-speed data signals within a tiny footprint.

Sustained data transfer rates equivalent to three parallel streams of high-definition video have been demonstrated in prototype components. Devices and customer evaluation boards are currently available for testing by qualified partners.

Dr. Carusone’s technology enables dramatic reductions in both cost and size while enabling significant performance improvements.

http://fotatech.com/

Read Introduction by MaRS: http://marsinnovation.com/company/fota-technologies/

1 Comment

July 28, 2013 · 10:28 pm

e-Therapeutics

Prime Minister opens e-Therapeutics drug discovery centre

e-Therapeutics completes £40m placing e-Therapeutics plc (AIM: ETX, http://www.etherapeutics.co.uk), a spinout from Newcastle University, is a drug discovery and development company which is pioneering network pharmacology, a new approach to the discovery of medicines.
On 1st March, e-Therapeutics announced the completion of two share placings that raised £40 million in new equity (approximately £39 million net). The new shares were priced at 32p, a premium of 4% to the price on previous dealing day. Following the funding, the company has net cash and liquid resources of approximately £48 million, which together with expected receipts from R&D tax credits and interest, are intended to support all of its currently planned discovery and development activities into 2017, by which time an outlicensing deal for the company’s lead cancer drug ETS2101 should be in place.
As a result of the latest investment, Invesco Asset Management now holds 45.9% of the company’s shares, together with Henderson Global Investors (12.1%), Octopus Group (6.3%), Newcastle University (4.9%), and founder Professor Malcolm Young (14.9%), in all accounting for 84.1% of the company.

Leave a comment

July 28, 2013 · 9:42 pm

PathXL

biobank3

PathXL (www.pathxl.com), is the winner of 2012 Deloitte Technology Fast 50 – a spin-out from Queen’s University Belfast established in 2005, is a pioneer in the use of web-based solutions for digital pathology, mainly in regard to cancer. Its PathXL™ Manager product provides a web-based platform to enable digital pathology users across all fields to manage, view and collaborate around virtual slides easily and efficiently. In addition, PathXL provides a range of applications and workflows to deliver specific solutions to pathologists, scientists and students in education, research, clinical and biobanking settings. PathXL also provides a full range of supporting services, including scanning, hosting, image analysis and consultancy.

Leave a comment

July 28, 2013 · 9:26 pm

MiDaz Laser

Midaz Lasers Ltd

homepage8On 31st Oct 2012 Coherent Inc announced its acquisition of MiDAZ Lasers, a spinout from Imperial College London started in 2006, at the same time acquiring Innolight Innovative Laser and Systemtechnik GmbH. Coherent believes that together these companies provide core technology building blocks for an emerging class of commercial, low cost, subnanosecond pulsed lasers for micro-electronics manufacturing. The patented MiDAZ technology enables simple amplifiers to be incorporated in a broad range of laser products delivering power scaling and long lasting performance in electrically efficient designs.
Innolight manufactures low power, short pulse lasers for industrial applications like silicon processing, and ultra-stable continuous wave lasers used in demanding scientific applications like atom trapping.

Founded in 1966, Coherent Inc (Nasdaq:COHR http://www.Coherent.com) provides photonics based solutions to the commercial and scientific research markets.

MIDAZ ltd, Bessemer Bldg, Prince Consort Rd
London SW7 2AZ, United Kingdom

URL:www.midaz.co.uk
Year Founded:2006

Leave a comment

July 28, 2013 · 8:26 pm

CYP Design

cyp
De Montfort University (DMU) has joined forces with Ithaka Life Sciences to market new technology invented by Prof Bob Chaudhuri, which will provide new products and services based on a set of proteins, named cytochrome P450s (CYPs). CYPs are found in the human liver and are mostly responsible for the metabolism of drugs in people. These proteins are commercially available for use by firms involved in the discovery of new drugs, but are inconvenient to use as they must be transported and stored at temperatures as low as minus 80 degrees Celsius.
The new technology from DMU allows CYPs to be shipped and handled at room temperature, eliminating the need for a cold chain. This will reduce the cost and make their use in testing new drugs much quicker and easier.
DMU and Ithaka have established a new company called CYP Design Ltd (CDL). DMU has licensed the new technology to CDL which will now bring the new products to market. Ithaka has worked closely with Prof Chaudhuri to set up CDL and is leading the implementation of the business strategy through Dr Bill Primrose as CEO and Dr Paul Rodgers as chairman.

http://www.cyp-design.com/

Leave a comment

July 28, 2013 · 8:18 pm

KERACOL

hair_swatch
Keracol  ‘functional, natural, sustainable cosmetics’,  is a spin-out company from the University of Leeds, producing cosmetic products for hair coloration, hair care and skin care using novel approaches to the extraction, fractionation and purification of natural active molecules in the cleanest, most energy efficient way.
The company was founded by Dr Richard Blackburn, Senior Lecturer in Coloration Technology, and Prof Christopher Rayner, Head of Organic Chemistry, at the University of Leeds. Prof Rayner previously founded C-Capture, and he and Dr Blackburn together founded DyeCat, both spinouts from Leeds.

Keracol Leeds healthcare products & services 16-Aug-11 http://www.keracol.co.uk

Leave a comment

July 28, 2013 · 8:11 pm

Impression Technologies

impressionsLogoHeader
Impression Technologies is an aluminium forming technology business based on intellectual property developed at Imperial College London.
The world’s automotive and transport industries will have to make a step change in their use of aluminium if they are to meet into complex shapes due to its limited ductility. Current technologies cannot meet the challenges faced in producing sophisticated shapes and structures for high volume applications cost effectively.
Prof Lin of Imperial College London and Dean of the University of Birmingham have developed the Hot Form Quench (HFQ) technology, which provides a cost-competitive means of producing lightweight, complex and structured aluminium components for the automotive, aerospace and rail industries.
In the patented HFQ process, an aluminium sheet is heated above its Solution Heat Treatment temperature, formed while hot, and quenched in the press. This process allows pressings to be formed which are lighter, deeper and with tighter radii than has been possible to date. The process is quicker and more costeffective than current methods, results in superior metallurgical properties, and allows stronger and lighter structures to be formed.
Impression Technologies is headed by CEO George Adam, an experienced automotive manager with over 30 years’ experience at GKN plc and ESAB China, and chairman Mike Foster, formerly CEO of Charter International plc, which he headed for five years following a career at GKN plc and Kvaener.http://www.impressiontech.ca/

Leave a comment

July 28, 2013 · 7:20 pm

Anacail

anacail

Anacail was formed to commercialise technology developed at the Glasgow University’s School of Physics and Astronomy. The technology can rapidly and safely turn some of the oxygen inside packaged food into ozone, a very effective germicide. Plasma generated by a retractable device held briefly against the surface of plastic or glass packaging splits the bonds between oxygen molecules (O2) inside the packaging which then reform as ozone (or O3). The ozone naturally returns to its original state after just a couple of hours – more than enough time for any mould, fungi or bacteria on the packaging’s contents to be destroyed without adversely affecting its taste.
The product’s effectiveness as a germ-killer also extends food’s shelf-life by at least one extra day, and has been proven at UK labs including Campden BRI in Gloucestershire, where tests have shown an increase in shelf-life for products including bread and muffins, and a significant reduction of many pathogens in poultry including campylobacter, pseudomonas, and E.coli. The name Anacail means ‘shield’, ‘preserve’ or ‘protect’ in Gaelic.

1 Comment

July 28, 2013 · 7:03 pm

Brainomix

logo-br2

Brainomix developed a software that allows expertise of a world class stroke assessment team to be accessible by any doctor in an emergency department.
Brainomix is led by managing director Dr Michalis Papadakis, along with co-founders Professor Iris Grunwald and Professor Alastair Buchan, Professor of Stroke Medicine and Head of the Medical Sciences Division at the University of Oxford.

e-ASPECTS automates the Alberta Stroke Program Early CT Score (ASPECTS) pioneered by Prof Buchan. Over the last 12 years ASPECTS has been adopted worldwide. The original ASPECTS system relies on a scoring system to assess CT (X-ray computed tomography) scans but requires a stroke expert to gauge the images. The automated e-ASPECTS encapsulates the expertise of Prof Buchan and his team in software that processes CT images. The software gives a score that can be used by any doctor to assist in deciding on an intervention where there is only a four and a half hour window for treatment from the onset of the stroke.http://www.brainomix.com/

Brainomix was set up by Isis Innovation, the technology transfer arm of the University of Oxford, and developed with the support of the National Institute for Health Research Oxford Biomedical Research Centre.

Leave a comment

July 28, 2013 · 6:48 pm

PAVEGEN

pavegen

..

Pavegen off-grid, interactive technology is highly engaging, bringing events and installations to life. Every time someone walks over a Pavegen tile, renewable energy is harvested from the footstep. The technology converts the kinetic energy to electricity which can be stored and used for a variety of applications. Pavegen worked with many of the world’s leading brands and organisations including Johnie Walker, WWF, Uniqlo, and Sainsbury’s helping to launch campaigns and ideas, powered by renewable energy.

West Ham station London Olympics, 2012

Central London Office installation

ur award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

ur award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

Our award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

Our award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

Leave a comment

July 23, 2013 · 6:32 pm

ISIS Software Incubator (ISI)

isis-software-incubator

The Isis Software Incubator (ISI) supports nascent software ventures in the development of products or services and assists them to trade without external investment.

The ISI has been supporting such ventures since late 2010 and launched an on-site incubation facility at Summertown, Oxford in mid 2011.

The ISI is currently accepting applications from entrepreneurs interested in joining our programme.

If you’d like to apply, have any questions, or would like to get in touch for a different reason, don’t hesitate to contact:

http://incubator.isis-innovation.com/

Leave a comment

July 22, 2013 · 7:47 pm

SVX

svx

INVEST FOR IMPACT

SVX is a local, impact investing platform connecting impact ventures, funds, investors and service providers to mobilize private capital towards public good.

Leave a comment

July 19, 2013 · 1:45 pm

Qvella

Canadian biotech company Qvella, headquartered in Toronto, is a molecular diagnostics company with new detection technology – preparing to bring a solution to the question of whether, and what, to prescribe when treating a possible infection is a problem.

If antibiotics are needed, they are most effective if used promptly – but the price of giving unnecessary treatment can be high, and includes not only the cost of the drugs themselves but also the growth of resistant strains of bacteria.

Currently, doctors can only get a definitive answer as to whether a patient is infected, and with what type of bacteria, after a sample from the patient is cultured in a lab, a process that takes between 24 and 72 hours. When a patient is in crisis, waiting that long simply isn’t an option. Sepsis, sometimes called a blood infection, is one such serious condition. It is the second cause of death among critical patients.

http://business.financialpost.com/2012/05/22/new-device-to-help-healthcare-workers-avoid-unnecessary-treatment/

https://www.htx.ca/Investment.aspx

Leave a comment

July 17, 2013 · 5:15 pm

DonorIQ

donor IQ

21 Century Fundraising Optimized

Increase your fundraising revenue by building personal relationships with all your donors – even the smallest ones.

http://donoriq.com/

42 Comments

July 10, 2013 · 6:47 pm

Encycle Therapeutics

ENCYCLElogo-JPEG-300x107

MaRS Innovation and CQDM had jointly collaborated to form Encycle Therapeutics, a startup that was created around disruptive technology, developed by Prof Andrei Yudin of the University of Toronto, involving the cyclization of biologically active peptides. A year later, I’m pleased to report that Encycle is alive and kicking. The company has since recruited seasoned management, and its developing product line is drawing tremendous interest from global pharmaceutical groups.

http://marsinnovation.com/

Leave a comment

July 5, 2013 · 12:40 am

Crowdmark

Crowdmark2-300x57

 

Aweekly online magazine that covers talent, innovation, diversity and quality of life stories in the Toronto region, covered Crowdmark‘s efforts to disrupt the way teachers grade and interact with students in their Innovation section on Wednesday, June 19, 2013.

Crowdmark graduated from the UTEST program earlier this spring. Last week, the company announced it has raised $600,000 in seed funding and completed two successful proof-of-concept pilot projects. Its co-founders are from the University of Toronto.

https://crowdmark.com/

Leave a comment

July 5, 2013 · 12:07 am

Whirlscape

Whirlscape-logo-296x300

Whirlscape Inc. released the beta version of its hotly anticipated, tiny, one-dimensional digital keyboard, Minuum: “the little keyboard for big fingers.”

If you follow tech gadget news, you’ve likely read about or even supported the company’s successful Indiegogo campaign, which raised more than US$87,000—over 870% above their modest initial goal of $10,000—from nearly 10,000 supporters who have now become beta users for the product.

The stats don’t end there. By number of funders, the Minuum Keyboard Project’s campaign is in Indiegogo’s top 10 of all time and is ranked No. 2 among all technology campaigns. Over 1.1 million people worldwide viewed Minuum’s original teaser video on YouTube, which the Whirlscape team edited and shot themselves.

Leave a comment

July 5, 2013 · 12:03 am

WestonExpressions

weston

Weston adapter enables screen to mobile interaction.

Increase consumer engagement through dynamic mobile & motion technology while generating analytics for your digital advertisement.

​For a limited time test their tech and win prizes!

Enter their marketers contest to access their online platform. Create an engaging experience through photos, videos and NFC technology to win prizes! Upload, edit, organize, manage, and schedule your digital signage content in real-time online. Display your message at the perfect moment, to the perfect consumer.

Leave a comment

July 2, 2013 · 11:49 pm

Thalmiclab

thalmiclab

Revolutionary Science

MYO lets you use the electrical activity in your muscles to wirelessly control your computer, phone, and other favorite digital technologies.

With a wave of your hand, MYO will transform how you interact with your digital world.

https://www.thalmic.com/myo/

Leave a comment

July 2, 2013 · 11:37 pm